-meran
Messenger RNA (mRNA) medicines and vaccines.
- Drugs ending in -meran: 17
- Approved somewhere: 2
- With a US drug page: 0
- Stem
- -meran
- Class
- Messenger RNA (mRNA) medicines and vaccines
- Most common targets
- S (3)
Approved and clinical-stage drugs in ChEMBL whose names ending in -meran, matched by spelling; those with a US drug page link to it.
| Acts on | |||
|---|---|---|---|
| Elasomeran | Approved | S | Spike glycoprotein vaccine antigen |
| Tozinameran | Approved | S | Spike glycoprotein vaccine antigen |
| Zorecimeran | Phase 3 | — | — |
| Abdavomeran | Phase 2 | S | Spike glycoprotein vaccine antigen |
| Andusomeran | Phase 2 | — | — |
| Intismeran autogene | Phase 2 | — | — |
| Pitozinameran | Phase 2 | — | — |
| Raxtozinameran | Phase 2 | — | — |
| Sapecmeran autogene | Phase 2 | — | — |
| Tegrenmeran | Phase 2 | — | — |
| Vintesomeran | Phase 2 | — | — |
| Enomimeran | Phase 1 | — | — |
| Ganulameran | Phase 1 | — | — |
| Gindameran | Phase 1 | — | — |
| Ontasameran | Phase 1 | — | — |
| Vibosameran | Phase 1 | — | — |
| Ziclumeran | Phase 1 | — | — |
Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO